A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 720 participants.

Also called NCT03172494

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 720 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03172494
Other papers using this trial's data
  • DUAL I China: Improved glycemic control with IDegLira versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs Journal of diabetes, 2022-06 DOI, PubMed 35762390, PMC9366571 PubMed links an erratum for this paper. Erratum: PMID 36125918; Erratum: PMID 36163590 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03172494. Randomized; no masking; primary purpose treatment. Start 2017-05-26 (actual); primary completion 2019-06-14 (actual). Results posted on 2020-07-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Acronym
DUAL™ I China
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Insulin degludec/liraglutide
Intervention (Drug)
Insulin degludec
Intervention (Drug)
Liraglutide
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct03172494
Content hash
5cf1f96ed011fb443eb7a13cf9b7932af8b1c7dd269269cea3b81225f27b3433